PATENT CLAIM ANALYSIS

Application Number: 16127440
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["424", "186100"]

Abstract:
Compositions, recombinant vaccines and live attenuated pathogens comprising one or more isolated nucleic acid molecules that encode an immunogen in combination with an isolated nucleic acid molecule that encodes IL-28 or a functional fragment thereof are disclosed. Methods of inducing an immune response in an individual against an immunogen, using such compositions are disclosed.

Claim (Index 21):
A method of immunizing an individual against a pathogen comprising administering to said individual a live attenuated pathogen comprising a nucleotide sequence that encodes IL-28 or a functional fragment thereof.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 97.0
- Lexical Diversity: 1.34884
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14263752', '12936192', '13391615', '14148359', '10560650']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7811174770182144
- 35 USC 102 Novelty (BERT): 0.6175558264136809
- Combined Prediction Score: 0.7647613119577611
- Mean Citation Score: 469.69547
- Max Citation Score: 586.04755
- Similarity Product: 518.6973120080859

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test